Dr Reddy’s Acquires Mayne Pharma’s USA Prescription Portfolio for $105 Million
Dr Reddy’s Laboratories (DRL) has entered into a definitive agreement to acquire Australia-based Mayne Pharma Group’s US generic for an upfront payment of $90 million...
Use UNICORN Signals App
By EquityPandit
